Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heated oxaliplatin infusion for prevention of acute oxaliplatin-induced peripheral neuropathy
NL-OMON19943Active, not recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Mar 2010
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of oxaliplatin in colorectal cancer (CRC), sponsored by St. Antonius Ziekenhuis. Primary endpoints: Reduction in acute peripheral neuropathy complaints and Quality of life change. Started Mar 2010; status: active, not recruiting.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NL-OMON19943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON19943.